Dr. Ihsan Salloum, MD
Claim this profileMore about Ihsan Salloum, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Ihsan Salloum, MD has experience with
- Allogeneic Human Mesenchymal Stem Cells
- Placebo
Breakdown of trials Ihsan Salloum, MD has run
Alcohol-Related Intimate Partner Violence
Major Depressive Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ihsan Salloum, MD specialize in?
Ihsan Salloum, MD focuses on Alcohol-Related Intimate Partner Violence and Major Depressive Disorder. In particular, much of their work with Alcohol-Related Intimate Partner Violence has involved treating patients, or patients who are undergoing treatment.
Is Ihsan Salloum, MD currently recruiting for clinical trials?
No, Ihsan Salloum, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Ihsan Salloum, MD has studied deeply?
Yes, Ihsan Salloum, MD has studied treatments such as Allogeneic Human Mesenchymal Stem Cells, Placebo.
What is the best way to schedule an appointment with Ihsan Salloum, MD?
Apply for one of the trials that Ihsan Salloum, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.